Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.
about
What We Have Learned about Autism Spectrum Disorder from Valproic AcidNeurophysiological and computational principles of cortical rhythms in cognitionCommon circuit defect of excitatory-inhibitory balance in mouse models of autism.Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.Synaptic Wnt/GSK3β Signaling Hub in AutismOn the Role of Glutamate in Presynaptic Development: Possible Contributions of Presynaptic NMDA ReceptorsThe role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.Changes in plasticity across the lifespan: cause of disease and target for interventionAnatomy and physiology of the thick-tufted layer 5 pyramidal neuronGestational valproate alters BOLD activation in response to complex social and primary sensory stimuli.Impaired Processing in the Primary Auditory Cortex of an Animal Model of Autism.Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in MiceThe Intense World Theory – A Unifying Theory of the Neurobiology of AutismAn Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment OutcomesSHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patientsFunctional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's diseaseTranslational regulation of NeuroD1 expression by FMRP: involvement in glutamatergic neuronal differentiation of cultured rat primary neural progenitor cellsPax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspringValidating γ oscillations and delayed auditory responses as translational biomarkers of autismValproate-induced neurodevelopmental deficits in Xenopus laevis tadpoles.Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?Mouse models of autism: testing hypotheses about molecular mechanisms.Prenatal VPA Exposure and Changes in Sensory Processing by the Superior ColliculusCognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice.Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.Low-dose thyroxine attenuates autism-associated adverse effects of fetal alcohol in male offspring's social behavior and hippocampal gene expression.Altering the trajectory of early postnatal cortical development can lead to structural and behavioural features of autism.Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines.Sex Differences in Autism-Like Behavioral Phenotypes and Postsynaptic Receptors Expression in the Prefrontal Cortex of TERT Transgenic MicemGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autismSubchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism.In utero exposure to valproic acid changes sleep in juvenile rats: a model for sleep disturbances in autism.Effects of atomoxetine on hyper-locomotive activity of the prenatally valproate-exposed rat offspringEffect of anodal transcranial direct current stimulation on autism: a randomized double-blind crossover trial.The amygdala excitatory/inhibitory balance in a valproate-induced rat autism modelThe transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy.The intense world syndrome--an alternative hypothesis for autismPrenatal exposure to drugs: effects on brain development and implications for policy and education.Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brainGlutamate receptor dysfunction and drug targets across models of autism spectrum disorders
P2860
Q21284783-1B1933A0-0967-42FD-BCF5-8553D4EA85D9Q24630528-C380D7DB-D228-4928-A761-79371898FC36Q26269924-E3B8296C-7D40-4602-86E5-67E9C7317B5FQ26748761-A6B6BA71-BEBA-4D9E-AF6B-48AC82995B3EQ26765504-87030B2C-0C21-4507-B486-D27414C40BE2Q26773295-069CFD57-DC33-4A40-9968-076D2D22CA5DQ26998975-08B391F3-3003-4D9E-96D6-F11F69C0D42FQ27022671-53914D88-57D0-41D5-B430-58C990C6CD3DQ27024125-B033864D-7918-451E-9BFB-64D7FCAE9354Q27302814-652C9AA3-5B25-48DB-99A6-6407ECE8B266Q27308689-5E0966D6-CCEF-4CDC-A68B-F44EAF736732Q27332438-FEAE4E5E-9AC6-4DC1-BCBD-187E9864330FQ27500386-E12E02E7-CA1D-4672-972C-3B38E0B50C09Q28081205-3D1F4EA0-3B32-4104-BDFE-74F8480584A4Q28300343-7791B238-05B7-4605-8DF6-3A25B80B7954Q28507781-CEBFB0CC-C870-4428-B34E-D6D4A9F41D5CQ28771393-49E6B6B9-5628-482B-8B54-030EE6282DDBQ28941206-6640EF16-FFE7-4727-8959-D529A3E94AF6Q30372103-C02A408A-1E53-46E6-9283-AD0B1AECA6BCQ30404772-6CCC7014-F6A6-4AD9-8A49-F1A060BB86B6Q30447994-26B6137C-8176-4DA4-B78F-3839B6CF1F71Q30465721-67EE1730-DCC1-42FC-A793-699FC7CC0509Q30473609-F79E7601-A777-4074-9834-16BFBAD40CE3Q30542135-CE46F3D9-45DB-42F7-9B07-2100D575A87CQ30549883-B2A2EF5F-EB52-4BB0-8FB6-DE2FB1DF57F1Q30552723-C1404E71-B07E-4DE0-A38E-C964CB83951DQ33665531-2C8E93DB-D423-4070-9EF4-944EE41F5D71Q33865755-20BB3652-A8BA-43BF-AA6F-D8149A769C98Q33878283-53BEF719-F982-4067-A851-EE2750960364Q34053492-6D83AF14-4E51-4260-B519-FBED0A079D0BQ34061622-89F48554-BA45-401D-AA8F-DB64A560F57AQ34125907-F8A03222-1FD2-474C-8F70-69474E299282Q34360515-47965FC1-BFE7-4494-BA24-A10D4BA7A661Q34501338-396C6BF6-5F02-4130-9074-11F1E6415ECFQ34576258-9E6AD352-B859-4FDD-ABD6-801A8D044483Q34679552-8B3CB531-7076-4D7B-BDD3-BBBBE4089782Q34871941-DFB0646A-1625-4C75-BAB4-EC3F9754C703Q34960692-1CDF604B-8377-44CB-B098-819A3182773FQ35003575-C49F3D52-3FF9-4363-BD95-0B4F4298388DQ35093810-0D60D407-A6F4-4A83-8388-0F92CF5B6F00
P2860
Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Elevated NMDA receptor levels ...... tal exposure to valproic acid.
@ast
Elevated NMDA receptor levels ...... tal exposure to valproic acid.
@en
type
label
Elevated NMDA receptor levels ...... tal exposure to valproic acid.
@ast
Elevated NMDA receptor levels ...... tal exposure to valproic acid.
@en
prefLabel
Elevated NMDA receptor levels ...... tal exposure to valproic acid.
@ast
Elevated NMDA receptor levels ...... tal exposure to valproic acid.
@en
P2093
P2860
P356
P1476
Elevated NMDA receptor levels ...... tal exposure to valproic acid.
@en
P2093
Karina Kulangara
Katia Antoniello
Tania Rinaldi
P2860
P304
13501-13506
P356
10.1073/PNAS.0704391104
P407
P577
2007-08-03T00:00:00Z